Diabetes Solutions Landscape Phase 4, Part 3

Part
01
of five
Part
01

Diabetes Solutions Landscape - Lifestyle US Sleep (IC 4)

Details of the identified digital solutions found in rows 8 to 17 (SmartSleep, Sleep Shepherd, Beddit 3 Sleep Monitor, BeVitalized, Oura Smart Ring, S+ By ResMed, Sleep Genius, EmFit Qs, Sleepace RestOn Z400T, and Kryo Sleep Performance System) have been provided in column N-S, US Sleep Full List tab. The focus of this research is to analyze if they fit Inclusion Criteria 4 (IC 4).

FINDINGS AND SUMMARY

Of the 10 digital solutions analyzed, one solution was identified to have not qualified any of the 5 criteria given for IC 4. BeVitalized (found in row 11), a digital sleep program from BeHealth Solutions, has planned the release in Q1 of 2018. It will target employers, wellness programs, and population health management plans. No significant media mentions were identified for this solution and it has not raised more than $3M funding. Also, no figures for its users are available as of the date and no available data was found for its clinical publications and outcomes. Hence, I've entered "No" for all 5 criteria.

CONCLUSION

Details of the 10 digital solutions found in rows 8 to 17 have been provided in column N-S (US Sleep Full List tab), including source links in column AO.

Part
02
of five
Part
02

Diabetes Solutions Landscape - Lifestyle US APPS (IC 3/4), Rows 8-14

All specified apps have a stated mission that is directed to either aid users to increase physical activity or improve nutrition. None of the specified applications fulfilled other points in criteria 3. Except for MyPlate Calorie Tracker, which states it has over one million installs and over 21,000 reviewers, user information was unavailable. The specified applications have received fewer than five publications across news media, social media, and blogs. Detailed information for each category is in the attached spreadsheet.

Methodology and Key Findings

We began searching for the specified company's mission statements in order to assess if they fulfilled criteria 3. All specified applications are designed to help improve diet or nutrition. MyPlate Calorie Tracker is also geared to increase physical activity of its users. CarbsControl and Nutrients are specifically targeted to diabetes patients. However, for all the other points in Criteria 3, the applications do not mention that they are used to target depression or sleep challenges, to identify cardio-metabolic diseases, to aid in smoking cessation, to adhere to cardio-metabolic medications, or to slow progression of cardio-metabolic diseases.
For Criteria 4, Point 1 i.e ONLY FOR MEDICAL DEVICES, the applications are lifestyle applications, not medical devices. Therefore, it is not applicable.

MyPlate Calorie Tracker is the only application that fulfilled a point in criteria 4. The app has over one million installs and over 21,000 reviews. This qualifies as over 10,000 users. Despite searching across Sensortower, Google Play Store, Apple App Store, Appannie, Appsflyers, to locate user data for the remaining applications, no information was available unless behind a paywall.

Despite searching across news publications, articles, and blogs funding information was not publicly available.

We then conducted a search on news, articles, social media, and blog publications to address the media attention received. There is less than five publication for all specified apps. No clinical outcomes have been published and there has not been any mention of ongoing studies for any of the apps in rows 8-14. Lastly, there is no relevant case study information available as the applications are not R&D or pharma-apps but instead lifestyle related.

Conclusion

The specified applications are designed to address user nutrition and diet. MyPlate is also geared to aid in physical fitness. The applications do not fulfill the other point in criteria 3. MyPlate user information was the only available information. The app has received over one million downloads and 21,000 user reviews. The specified applications do not qualify as medical devices and no relevant case study information is available. The applications have received minimal media attention with less than five mentions in media to date. Detailed information is available in the attached spreadsheet.
Part
03
of five
Part
03

Diabetes Solutions Landscape - Lifestyle US APPS (IC 3/4), Rows 15-20

Information on diabetes digital health solutions that enable behavioral changes are indicated in the linked spreadsheet.
Part
04
of five
Part
04

Diabetes Solutions Landscape - CM US APPS (IC 3/4), Rows 8-12

Detailed results of our findings can be found in this spreadsheet.
Part
05
of five
Part
05

Diabetes Solutions Landscape - CM US APPS (IC 3/4), Rows 13-17

Please see the attached spreadsheet.
Sources
Sources

From Part 01
From Part 03